Erschienen in:
18.04.2023 | Commentary
Commentary: magnetic resonance spectroscopy and liquid chromatography-mass spectrometry metabolomics study may differentiate pre-eclampsia from gestational hypertension
verfasst von:
Ante Zhu
Erschienen in:
European Radiology
|
Ausgabe 7/2023
Einloggen, um Zugang zu erhalten
Excerpt
Pre-eclampsia is a serious pregnancy complication characterized by the new onset of hypertension, proteinuria that indicates kidney damage, or significant dysfunction of other organs. It typically develops after 20 weeks of gestation and affects about 4.6% of all pregnancies worldwide. Mothers may develop headaches, visual deficits, acute renal failure, liver injury, pulmonary edema, stroke, etc. In the most severe cases, seizures (eclampsia) might appear. Pre-eclampsia and eclampsia cause 14% of maternal deaths each year, or about 75,000 mothers worldwide [
1]. Pre-eclampsia may also affect the placenta, leading to placental abruption, preterm birth, fetal growth restriction, pregnancy loss, or stillbirth. …